Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.

Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, Deng Y, Shuai Y, Jin J, Lu L.

Eur J Pharmacol. 2008 Jan 28;579(1-3):160-6. Epub 2007 Oct 10.

PMID:
17977528
2.

[Methadone treatment and its dangers].

Reingardiene D, Jodziƫniene L, Lazauskas R.

Medicina (Kaunas). 2009;45(5):419-25. Review. Lithuanian.

3.

Methadone maintenance treatment (MMT): a review of historical and clinical issues.

Joseph H, Stancliff S, Langrod J.

Mt Sinai J Med. 2000 Oct-Nov;67(5-6):347-64. Review.

PMID:
11064485
4.

Rationale for maintenance pharmacotherapy of opiate dependence.

Kreek MJ.

Res Publ Assoc Res Nerv Ment Dis. 1992;70:205-30. Review.

PMID:
1346939
5.

Effect of methadone maintenance treatment on heroin craving, a literature review.

Fareed A, Vayalapalli S, Stout S, Casarella J, Drexler K, Bailey SP.

J Addict Dis. 2011 Jan;30(1):27-38. doi: 10.1080/10550887.2010.531672. Review.

PMID:
21218308
6.

Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?

Gerra G, Maremmani I, Capovani B, Somaini L, Berterame S, Tomas-Rossello J, Saenz E, Busse A, Kleber H.

Subst Use Misuse. 2009;44(5):663-71. doi: 10.1080/10826080902810251. Review.

PMID:
19360539
7.

Neurobiology of addictive behaviors and its relationship to methadone maintenance.

Stimmel B, Kreek MJ.

Mt Sinai J Med. 2000 Oct-Nov;67(5-6):375-80. Review.

PMID:
11064487
8.

[Heroin addiction].

Hosztafi S.

Acta Pharm Hung. 2011;81(4):173-83. Review. Hungarian.

PMID:
22329304
9.

[Buprenorphine as maintenance treatment in rehabilitation of heroin addicts].

Bramness JG, Bachs LC, Waal H.

Tidsskr Nor Laegeforen. 2002 Oct 20;122(25):2452-4. Review. Norwegian.

PMID:
12448114
10.

Regulation of the dopamine transporter by phosphorylation.

Foster JD, Cervinski MA, Gorentla BK, Vaughan RA.

Handb Exp Pharmacol. 2006;(175):197-214. Review.

PMID:
16722237
11.

Understanding polydrug use: review of heroin and cocaine co-use.

Leri F, Bruneau J, Stewart J.

Addiction. 2003 Jan;98(1):7-22. Review.

PMID:
12492751
12.

Treatment of neonatal abstinence syndrome.

Johnson K, Gerada C, Greenough A.

Arch Dis Child Fetal Neonatal Ed. 2003 Jan;88(1):F2-5. Review.

13.

Clonidine treatment of the opiate withdrawal syndrome. A review of clinical trials of a theory.

Agren H.

Acta Psychiatr Scand Suppl. 1986;327:91-113. Review. No abstract available.

PMID:
3529831
14.

The effects of methadone on immune function among injecting drug users: a review.

McLachlan C, Crofts N, Wodak A, Crowe S.

Addiction. 1993 Feb;88(2):257-63. Review.

PMID:
8220063
16.

PE2I: a radiopharmaceutical for in vivo exploration of the dopamine transporter.

Emond P, Guilloteau D, Chalon S.

CNS Neurosci Ther. 2008 Spring;14(1):47-64. doi: 10.1111/j.1527-3458.2007.00033.x. Review.

PMID:
18482099
17.

Disciplining addictions: the bio-politics of methadone and heroin in the United States.

Bourgois P.

Cult Med Psychiatry. 2000 Jun;24(2):165-95. Review.

PMID:
10885786
18.
19.

The dopamine transporter proteome.

Torres GE.

J Neurochem. 2006 Apr;97 Suppl 1:3-10. Review.

20.

[Importance of methadone maintenance in the treatment of heroin and other opioid dependence--a current perspective].

Kaminer Y.

Harefuah. 1993 Dec 1;125(11):429-33. Review. Hebrew. No abstract available.

PMID:
8112673

Supplemental Content

Support Center